DK167171B1 - Fremgangsmaade til fremstilling af et stabilt nicorandilholdigt farmaceutisk praeparat - Google Patents
Fremgangsmaade til fremstilling af et stabilt nicorandilholdigt farmaceutisk praeparat Download PDFInfo
- Publication number
- DK167171B1 DK167171B1 DK583385A DK583385A DK167171B1 DK 167171 B1 DK167171 B1 DK 167171B1 DK 583385 A DK583385 A DK 583385A DK 583385 A DK583385 A DK 583385A DK 167171 B1 DK167171 B1 DK 167171B1
- Authority
- DK
- Denmark
- Prior art keywords
- nicorandil
- tablet
- acid
- mannitol
- tablets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59265888A JPH0653658B2 (ja) | 1984-12-17 | 1984-12-17 | 安定な錠剤の製造法 |
JP26588884 | 1984-12-17 | ||
JP14968885 | 1985-07-08 | ||
JP14968885 | 1985-07-08 | ||
JP21327785 | 1985-09-26 | ||
JP21327785 | 1985-09-26 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK583385D0 DK583385D0 (da) | 1985-12-16 |
DK583385A DK583385A (da) | 1986-06-18 |
DK167171B1 true DK167171B1 (da) | 1993-09-13 |
Family
ID=27319808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK583385A DK167171B1 (da) | 1984-12-17 | 1985-12-16 | Fremgangsmaade til fremstilling af et stabilt nicorandilholdigt farmaceutisk praeparat |
Country Status (23)
Country | Link |
---|---|
US (1) | US4803213A (pt) |
EP (1) | EP0185347B1 (pt) |
JP (1) | JPH0653658B2 (pt) |
KR (1) | KR930007251B1 (pt) |
CN (1) | CN1007209B (pt) |
AR (1) | AR241515A1 (pt) |
AT (1) | ATE54050T1 (pt) |
AU (1) | AU579431B2 (pt) |
BA (1) | BA98214B1 (pt) |
CA (1) | CA1255227A (pt) |
DE (1) | DE3578373D1 (pt) |
DK (1) | DK167171B1 (pt) |
FI (1) | FI84781C (pt) |
HK (1) | HK65493A (pt) |
HU (1) | HU195731B (pt) |
IE (1) | IE59158B1 (pt) |
MX (1) | MX166095B (pt) |
NO (1) | NO171826C (pt) |
PT (1) | PT81680B (pt) |
RU (1) | RU1811401C (pt) |
SG (1) | SG52493G (pt) |
YU (1) | YU45292B (pt) |
ZA (1) | ZA859390B (pt) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5188840A (en) * | 1985-09-26 | 1993-02-23 | Chugai Seiyaku Kabushiki Kaisha | Slow-release pharmaceutical agent |
KR950010150B1 (ko) * | 1986-01-14 | 1995-09-11 | 쥬우가이세이야꾸 가부시끼가이샤 | 니코란딜 함유 주사제의 안정화 방법 |
KR940000232B1 (ko) * | 1986-01-17 | 1994-01-12 | 쥬우가이세이야꾸 가부시끼가이샤 | 니코란딜 제제의 안정화 방법 |
GR871267B (en) * | 1986-08-18 | 1987-12-24 | Chugai Pharmaceutical Co Ltd | Method for the manufacture of a pharmaceutical preparation for administration by percutaneous absortion |
US4940580A (en) * | 1986-11-03 | 1990-07-10 | Schering Corporation | Sustained release labetalol tablets |
CA1322957C (en) * | 1988-03-30 | 1993-10-12 | Hitoshi Yamauchi | Cyclic amp derivative ointments |
JP2535141B2 (ja) * | 1995-01-17 | 1996-09-18 | 中外製薬株式会社 | フマル酸含有徐放性製剤 |
US6235947B1 (en) * | 1997-04-14 | 2001-05-22 | Takeda Chemical Industries, Ltd. | D-mannitol and its preparation |
HUP9902165A3 (en) | 1996-04-16 | 2001-01-29 | Bayer Ag | D-mannit and with big specific surface area process for preparing it and solid pharmaceuticals containing it |
KR100481583B1 (ko) * | 1996-06-14 | 2005-07-12 | 교와 핫꼬 고교 가부시끼가이샤 | 구강내에서빠르게붕괴하는정제 |
AU733032C (en) * | 1996-06-14 | 2002-01-03 | Kyowa Hakko Kirin Co., Ltd. | Intraorally rapidly disintegrable tablet |
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
IT1293835B1 (it) * | 1997-08-08 | 1999-03-10 | Foscama Biomed Chim Farma | Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione |
US6417207B1 (en) | 1999-05-12 | 2002-07-09 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
KR100483080B1 (ko) * | 2001-09-21 | 2005-04-14 | 한인규 | 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제 |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US8367111B2 (en) * | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
JP4235149B2 (ja) | 2004-07-02 | 2009-03-11 | インターナショナル・ビジネス・マシーンズ・コーポレーション | ノートブック型コンピュータ |
US8747895B2 (en) * | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
NZ589750A (en) | 2004-10-21 | 2012-07-27 | Aptalis Pharmatech Inc | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
CN100417381C (zh) * | 2006-02-09 | 2008-09-10 | 西安力邦医药科技有限责任公司 | 尼可地尔冻干粉的制备方法 |
US20090076095A1 (en) * | 2007-09-15 | 2009-03-19 | Protia, Llc | Deuterium-enriched nicorandil |
GB0720516D0 (en) * | 2007-10-18 | 2007-11-28 | Cadbury Schweppes Plc | Comestible products |
ES2668203T3 (es) | 2009-12-02 | 2018-05-17 | Adare Pharmaceuticals S.R.L. | Microcápsulas de fexofenadina y composiciones que las contienen |
WO2011085181A1 (en) * | 2010-01-08 | 2011-07-14 | Eurand, Inc. | Taste masked topiramate composition and an orally disintegrating tablet comprising the same |
CN111606847B (zh) * | 2020-05-26 | 2021-12-31 | 中国科学院上海药物研究所 | 尼可地尔与1-羟基-2-萘甲酸的共晶及其制备方法和应用 |
CN114732792A (zh) * | 2022-03-25 | 2022-07-12 | 北京诺康达医药科技股份有限公司 | 一种尼可地尔口腔崩解片及其制备方法 |
CN115317456A (zh) * | 2022-08-17 | 2022-11-11 | 北京科源创欣科技有限公司 | 一种尼可地尔片组合物及其制备方法 |
CN115282123B (zh) * | 2022-09-13 | 2023-11-03 | 南京比逊医药科技有限公司 | 一种稳定的尼可地尔制剂的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3168438A (en) * | 1962-08-09 | 1965-02-02 | Synergistics Inc | Vasodilation by nitric acid ester derivatives of nicotinic acid |
US3332848A (en) * | 1963-07-10 | 1967-07-25 | Hoffmann La Roche | Microcrystalline cellulose with starch in niacinamide ascorbic acid tablet granulations |
US3577491A (en) * | 1968-01-02 | 1971-05-04 | Miles Lab | Tableting |
DK145608C (da) * | 1976-04-02 | 1983-07-11 | Chugai Pharmaceutical Co Ltd | Analogifremgangsmaade til fremstilling af salpetersyreesteren af n-(2-hydroxyethyl)nicotinamid |
US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
JPS599539B2 (ja) * | 1979-11-13 | 1984-03-03 | 日本化薬株式会社 | ニトログリセリン水溶液及びその製造法 |
DE3175410D1 (en) * | 1980-07-29 | 1986-11-06 | Sanofi Sa | Acid stabilized compositions of thieno-pyridine derived compounds and process for preventing degradation of such compounds |
US4490377A (en) * | 1980-07-29 | 1984-12-25 | Syntex (U.S.A.) Inc. | Acid stabilized compositions of thieno-pyridine derived compounds |
US4382091A (en) * | 1981-04-30 | 1983-05-03 | Syntex (U.S.A.) Inc. | Stabilization of 1-substituted imidazole derivatives in talc |
JPS5885819A (ja) * | 1981-11-17 | 1983-05-23 | Chugai Pharmaceut Co Ltd | 気管支拡張剤 |
DK150008C (da) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
DE3244178A1 (de) * | 1982-11-30 | 1984-05-30 | Bayer Ag, 5090 Leverkusen | 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
-
1984
- 1984-12-17 JP JP59265888A patent/JPH0653658B2/ja not_active Expired - Lifetime
-
1985
- 1985-12-04 AU AU50762/85A patent/AU579431B2/en not_active Expired
- 1985-12-06 CA CA000497114A patent/CA1255227A/en not_active Expired
- 1985-12-09 ZA ZA859390A patent/ZA859390B/xx unknown
- 1985-12-12 AR AR85302556A patent/AR241515A1/es active
- 1985-12-16 HU HU854801A patent/HU195731B/hu unknown
- 1985-12-16 RU SU853993193A patent/RU1811401C/ru active
- 1985-12-16 AT AT85116032T patent/ATE54050T1/de not_active IP Right Cessation
- 1985-12-16 IE IE317685A patent/IE59158B1/en not_active IP Right Cessation
- 1985-12-16 DK DK583385A patent/DK167171B1/da not_active IP Right Cessation
- 1985-12-16 DE DE8585116032T patent/DE3578373D1/de not_active Expired - Lifetime
- 1985-12-16 EP EP85116032A patent/EP0185347B1/en not_active Expired - Lifetime
- 1985-12-16 KR KR1019850009452A patent/KR930007251B1/ko not_active IP Right Cessation
- 1985-12-16 NO NO855048A patent/NO171826C/no not_active IP Right Cessation
- 1985-12-16 PT PT81680A patent/PT81680B/pt unknown
- 1985-12-17 FI FI855032A patent/FI84781C/fi not_active IP Right Cessation
- 1985-12-17 YU YU1973/85A patent/YU45292B/xx unknown
- 1985-12-17 MX MX000985A patent/MX166095B/es unknown
- 1985-12-17 CN CN85109190A patent/CN1007209B/zh not_active Expired
-
1988
- 1988-01-21 US US07/147,129 patent/US4803213A/en not_active Expired - Lifetime
-
1993
- 1993-04-23 SG SG52493A patent/SG52493G/en unknown
- 1993-07-08 HK HK654/93A patent/HK65493A/xx not_active IP Right Cessation
-
1998
- 1998-04-27 BA BA980214A patent/BA98214B1/bs active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK167171B1 (da) | Fremgangsmaade til fremstilling af et stabilt nicorandilholdigt farmaceutisk praeparat | |
US4950484A (en) | Pharmaceutical tablet, pharmaceutical granulate and process for their preparation | |
US3873694A (en) | Direct compression tabletting composition and pharmaceutical tablets produced therefrom | |
AU643920B2 (en) | Stabilized solid chemical compositions | |
FI87043B (fi) | Foerfarande foer framstaellning av ett stabilt farmaceutiskt preparat som innehaoller nikorandil. | |
CN101721410B (zh) | 硫酸氢氯吡格雷的固体药物组合物 | |
CN103070864A (zh) | 一种瑞格列奈和盐酸二甲双胍药物组合物及其制备方法 | |
CN104582731A (zh) | 含有左甲状腺素的固体药物制剂 | |
US4601895A (en) | Delayed-action acetylsalicylic acid formulations for oral administration | |
JP2512302B2 (ja) | ニコランジル安定化製剤の製造方法 | |
JP2532224B2 (ja) | ニコランジル錠剤の製法 | |
RU2326660C1 (ru) | Пероральный лекарственный препарат мемантин (варианты) и способ его получения (варианты) | |
CN101460191A (zh) | 包含湿敏性药物的稳定制剂及其制备方法 | |
AU2003201879B2 (en) | Pharmaceutical composition comprising 2,2-Dichloro-12-(4-chlorophenyl)-dodecanoic acid | |
Magar | FORMULATION AND EVALUTION OF ORAL DISPERSIBLE TABLETS | |
RU2762552C2 (ru) | Фармацевтическая композиция оксиэтиламмония метилфеноксиацетата | |
EP1563835A1 (en) | Hydroxypropylmethylcellulose capsule preparation having teprenone encapsulated therein | |
CN85101820A (zh) | 制备一种硝苯吡啶复合制剂的方法 | |
CN115282123A (zh) | 一种稳定的尼可地尔制剂的制备方法 | |
CN115317456A (zh) | 一种尼可地尔片组合物及其制备方法 | |
RU2149001C1 (ru) | Ноотропное лекарственное средство и способ его получения | |
CN112641745A (zh) | 一种替米沙坦氢氯噻嗪片剂及其制备方法 | |
RU2266106C1 (ru) | Способ получения антимикробного средства | |
MX2007015359A (es) | Preparacion farmaceutica solida que contiene (r)-(-)-2-[5-(4- fluorofenil)-3-piridilmetilaminometil]-cromano. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PUP | Patent expired |